Tianjin Pharma's Indonesian JV a stepping stone to international expansion
This article was originally published in Scrip
Executive Summary
While many big Chinese pharma companies are looking at the US market to take their first international steps, Tianjin Pharma, a state-owned group and the local partner in GlaxoSmithKline's joint venture in China, has decided to begin its planned global expansion in Southeast Asia.